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Increasing numbers of parathyroid procedures are being
performed worldwide.1 Indeed, in some countries, the increase
appears to be exponential.2 There are several apparent reasons
for this change. In a recent editorial in the New England Journal
of Medicine, Utiger recommended parathyroidectomy for nearly
all patients with primary hyperparathyroidism based on the
dual view that “most patients with primary hyperpara-
thyroidism probably have symptoms” and that changes in
surgical technique have made “surgical treatment simpler
and faster than in the past”.3 With respect to the first reason
given, it is now recognized that parathyroidectomy is likely to
benefit patients with a multitude of symptoms, including
reduced bone mineral density or osteoporosis, kidney stones,
non-specific neuromuscular symptoms including fatigue,
lethargy and muscle weakness, mental changes, cardiovascular
disease and diabetes.4–11 In addition, even patients who, by all
criteria, would be considered to be “asymptomatic” have been
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shown to have an improved sense of wellness following
parathyroidectomy.12
The introduction of MIP appears to be another possible
reason for the progressive increase in referrals for parathyroi-
dectomy. The various techniques reported have included a full
endoscopic approach with gas insufflation,13,14 video-assisted
approaches,15–17 and the direct focused approach using a
small cervical incision.18 A variety of techniques have been
introduced to ensure removal of all abnormal parathyroid
tissue, including the rapid intraoperative measurement of
parathyroid hormone (PTH, IO-QPTH)19 and the intra-
operative nuclear probe.20 These techniques mean that
parathyroidectomy can now be offered as a 1-hospital-day
only, local anaesthetic procedure, with a small incision, minimal
complications and a success rate equal to the previous “gold
standard” of open four-gland exploration.21
Despite these apparent advantages, there has always been
the concern that the introduction of MIP was a “market-
driven exercise” solely aimed at promoting a “minimally
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invasive” procedure in order to increase local referrals. Websites
can still be accessed that claim unsubstantiated advantages of
the minimally invasive approach and promote referral to the
surgical centre concerned.22 Against this background,
endocrine surgeons in Australia agreed that MIP was a
procedure that should only be introduced across the nation on
the basis of evidence-based guidelines and protocols.
MIP and ASERNIP-S
Following the publication of a small case series describing the
technique of endoscopic parathyroidectomy in the Australia
and New Zealand Journal of Surgery in 1998,23 endocrine sur-
geons in Australia agreed at their annual meeting in May 1998
that MIP should be introduced into Australia under the
auspices of the Australian Safety and Efficacy Register of New
Interventional Procedures – Surgical (ASERNIP-S). This
organization is a federally funded body working through the
Royal Australasian College of Surgeons. The process for
introducing new surgical procedures involves the following
steps: systematic review, recommendation on the appropri-
ateness or otherwise of the procedure, feasibility or controlled
clinical trials, and finally, reassessment of the procedure in the
light of any new information.24
A systematic review was completed and co-published in the
Australia and New Zealand Journal of Surgery and Archives of
Surgery in April 2000.25,26 The authors reported that there were
insufficient data in relation to the safety and efficacy of MIP,
and that no firmly established method had been accepted as
the standard technique. They recommended that ongoing
monitoring and further controlled studies were required to
ensure that MIP reached the high degree of satisfaction noted
with open parathyroidectomy. On the basis of that report,
ASERNIP-S then recommended that MIP be classified
as a “level 2.2 procedure”, i.e. that “the safety and/or efficacy
of the procedure cannot be determined due to an incom-
plete and/or poor evidence base. A controlled clinical trial is
required.”
Various endocrine surgical units around Australia
submitted proposals to undertake feasibility studies of
MIP using a variety of techniques including endoscopic
parathyroidectomy, video- or endoscopic-assisted parathyroi-
dectomy, minimal incision parathyroidectomy with IO-QPTH
measurement, and radio-guided parathyroidectomy. We at
Royal North Shore Hospital (RNS) initially undertook a
feasibility study of endoscopic-assisted MIP under the auspices
of ASERNIP-S.
Endoscopic-assisted MIP at RNS
A technique of endoscopic-assisted MIP was developed that
was an adaptation of the previous reports of Miccoli et al,17
Yeung and Ng23 and others. The technique employed a 2.5-cm
central suprasternal incision, with creation of a space by finger
dissection and the use of an external lift-device.27 A separate
stab incision was made posterior to the sternomastoid muscle
and a 4.4-mm telescope was inserted to visualize the space. The
adenoma was dissected and removed through the suprasternal
incision. In an initial report of 100 consecutive parathyroid
procedures, 24 were performed endoscopically. The outcomes
of the endoscopic-assisted technique were not statistically
different from the open parathyroidectomies, with only one
case of persistent hyperparathyroidism that was cured by
subsequent open surgery. Two patients had temporary
recurrent nerve neuropraxia, which resolved within several
weeks of surgery.27 At this stage, a second feasibility study of
the minimal incision technique using the focused lateral
approach was started. Altogether, a total of 49 endoscopic-
assisted parathyroidectomies were performed at RNS before
changing over completely to the focused lateral approach. One
reason for changing was that, frequently during the finger
dissection necessary to create the working space for the
telescope, the parathyroid adenoma would be encountered. It
was soon apparent that it would be much easier and quicker to
simply remove it under direct vision rather than continuing
with a formal endoscopic-assisted dissection and removal.
Focused, lateral, minimal incision
parathyroidectomy at RNS
A technique of MIP using the lateral focused approach was
developed.18 The principle of this technique is that a very small
incision is made directly over the site of a previously localized
parathyroid adenoma, which is then removed under direct
vision (Figure 1).  The procedure is offered with either local
anaesthesia, or local anaesthetic infiltration supplemented by
a laryngeal mask, with 96% of patients choosing the latter
option. The lateral approach provides more direct access to
parathyroid-bearing areas than does a central incision, and
also appears to result in better cosmesis. The technique involves
a 2-cm incision placed lateral to the medial margin of the
sternomastoid muscle, and in a position, depending upon
localization, to a superior or inferior gland. A working space is
developed with finger dissection, the sternomastoid is retracted
laterally, and dissection is continued lateral to the strap muscles
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and lateral to the thyroid fascia, down to the prevertebral
fascia. After division of the middle thyroid vein, a superior
parathyroid adenoma will commonly be found in the tracheo-
oesophageal groove, whilst an inferior gland is found in the
thyrothymic area, inferior to the lower pole of the thyroid.
A prospective, randomized controlled study comparing
open parathyroidectomy with focused lateral MIP was
undertaken prior to changing completely to the latter
technique. Thirty consecutive patients (15 in each group)
presenting for parathyroidectomy and fitting the selection
criteria for a minimally invasive approach were included after
obtaining informed consent. Outcome measures included
cure rate (serum calcium at 6 mo), operative time, postoperative
complications and length of stay. There was no significant
difference between the two groups with respect to cure rate,
with 100% cured in both groups. There was no significant
difference in postoperative complications, with one case of
temporary neurapraxia in the lateral focused group that
resolved after 6 weeks. The length of stay was the same in both
groups (whole group mean ± SD, 1.2 ± 0.51 days), with
the only difference being in the operative time (endoscopic-
assisted, 75 ± 12.3 min; lateral focused, 44 ± 8.4 min [p < 0.05]).
It must be noted that this is the entire time in the operating
room; actual surgical times were, of course, much shorter, with
the fastest surgical time for a lateral focused approach being
only 12 minutes.
Initial experience with the technique was promising. In a
report of the first 100 consecutive cases, there were three
negative neck explorations and a conversion rate to open
parathyroidectomy of 7%, with minimal morbidity.28 From
May 1999 to October 2002, 357 MIPs were performed at RNS.
Cure rate was high at 98.5%, with six failed explorations, all
cured at subsequent open surgery. In five of these cases, the
failure was due to incorrect imaging, whilst in one case, it was
due to the presence of parathyroid hyperplasia. There were
three cases of permanent recurrent laryngeal nerve palsy
(0.8%), and one bleed requiring re-operation.
The key to such success is appropriate selection of cases.
Patients considered suitable for MIP using this approach are
patients where localization studies (sestamibi nuclear scan
and ultrasound) are concordant and confirm the presence of
a single parathyroid adenoma (about 43% of all patients
presenting for surgery). Excluded are patients with any of the
following: previous neck surgery or irradiation, presence of a
large multinodular goitre (minimal multinodular change is
not an exclusion criterion), possibility of hyperplasia (e.g.
multiple endocrine neoplasia syndrome or secondary
Figure 1. Schematic diagrams showing focused, lateral, minimal
incision parathyroidectomy techniques: A) siting of incisions for superior
(a) and inferior (b) adenomas; B) dissection for an inferior adenoma
at the lower pole of the thyroid and C) dissection for a superior
adenoma in the tracheo-oesophageal groove. Reproduced here with
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hyperparathyroidism) and failure to localize to a single site.
All such patients are offered a standard, open, four-gland
parathyroidectomy.
Assessment of completeness of
parathyroid resection
A number of techniques have been described to assess
completeness of resection of abnormal parathyroid tissue,
including IO-QPTH,19 nuclear probe20 and visualization of a
normal ipsilateral parathyroid gland.29 Despite earlier
enthusiasm, interest in the use of the nuclear probe has waned
due to concerns about its reliability and accuracy.30 IO-QPTH
remains the most popular technique, being used by 68% of
surgeons according to an international survey.1 Our own
experience with IO-QPTH has shown that, although it is a very
accurate technique, it often fails in the presence of double
adenomas.31 In other words, it is a very good technique when
you do not need it, as the patient will have been cured anyway
by removal of a single adenoma in 97% of cases. However, it is
less useful in the presence of multigland pathology.
Furthermore, there is a significant false-positive rate (6%),
such that if the standard criteria are used, a number of patients
will undergo an unnecessary conversion to an open procedure.
As such, the technique, whilst accurate, cannot really be
regarded as cost-effective.32
We use the technique of simply determining PTH levels
preoperatively and 30 minutes postoperatively, as measured
on a routine laboratory run. This is less expensive and as
accurate as IO-QPTH. Furthermore, it still allows for same-
day patient discharge for the 97% of patients who will have
been cured anyway by removal of a single adenoma. False
positives with unnecessary conversion can be avoided by
repeating the PTH and calcium levels later that evening for
patients whose 30-minute PTH was elevated. The very small
percentage (< 2%) of patients with a true failed operation can
undergo open surgery during the same hospital admission,
usually the next morning.
Trends in parathyroid surgery
Of interest is the effect that the introduction of MIP has had
upon referrals for parathyroid surgery. In the past few years,
referrals for parathyroid surgery to RNS have increased
exponentially (Figure 2).2 Whilst there are a number of factors
that may well have contributed to such a dramatic increase,
one factor is clearly the availability of MIP and the perception
by referring endocrinologists that there is now a procedure
that is simpler, easier and can be performed on a 1-hospital-
day only basis, with safety and efficacy equal to the standard,
four-gland, open exploration operation.
A similar pattern of increasing referrals for parathyroid
surgery seems to be occurring worldwide. In a recent previous
study, we demonstrated that there has been an increase in
parathyroid surgery worldwide,1 a pattern that other
individuals have also reported.33 At the time of our survey
(May 2000), the majority (56%) of endocrine surgeons
worldwide were offering MIP and were performing it, on
average, in 49% of cases. Of further interest was that the
focused minimal incision approach had become the standard
technique used, being employed by 92% of those responding to
the international survey. Many surgeons reported starting
endoscopic or video-assisted parathyroid surgery and then
moving to the focused minimal incision technique because it
was quicker, easier and produced equivalent cosmetic results
and clinical outcomes.
It was interesting to read a comment by Ng, the author of
the very article that initially galvanized Australian endocrine
surgeons to undertake a formal approach to the introduction
of MIP, in a recent issue of the Australia and New Zealand Journal
of Surgery.34 He wrote, “Very quickly I realized, as did Australian
endocrine surgeons, that a parathyroid adenoma could be
expeditiously removed under direct vision through a 2-cm
incision directly over the preoperatively localized site without
the utilization of unnecessarily complex endoscopic or
endoscopic-assisted techniques.” Similarly, Ikeda and Takami,
in a recent monograph on minimally invasive endocrine
surgery, commented that “endoscopic and video-assisted
Figure 2. Referrals to the University of Sydney Endocrine Surgical
Unit for parathyroidectomy (1962–2001). Reproduced here with
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techniques reduce the level of invasiveness...however, these
procedures are time-consuming and their complexity renders
them difficult to reproduce in all surgical backgrounds...the
mini-incision approach...simplifies the procedure, enabling
the latter to be less technically demanding and time consuming
while improving cosmesis”.35 It appears that the initial
enthusiasm for technologically driven, endoscopic procedures
has abated (at least in Australia and some parts of Asia), and
that the focused, or mini-incision approach is now an accepted
standard of care.
Regardless of what technique is used, the introduction
of MIP has challenged the role of the gold standard of
conventional open parathyroidectomy, and has led to
increasing referrals for parathyroid surgery.33
Conclusion
MIP was introduced into Australia only following an evidence-
based review, and in the context of feasibility studies conducted
under the auspices of ASERNIP-S, a federally funded body
operating through the Royal Australasian College of Surgeons,
which monitors the introduction of new surgical procedures.
The lateral, focused, minimal incision technique has become
the surgical approach favoured by most surgeons, and provides,
in appropriately selected cases, a cure rate of 98%, with minimal
morbidity. The introduction of MIP has resulted in a significant
rise in referrals for parathyroid surgery.
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